Showing results (101-110 of 231) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast densityCaroline Diorio, Michael Pollak, Celia Byrne, et al.
The Lancet. Oncology|October 7, 2008
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysisJing Ma, Haojie Li, Ed Giovannucci, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 18, 2016
Agreement between circulating IGF-I, IGFBP-1 and IGFBP-3 levels measured by current assays versus unavailable assays previously used in epidemiological studiesChino S Aneke-Nash, Clara Dominguez-Islas, Petra Bůžková, et al.
Plos One|November 22, 2013
Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allograftsHenning Hvid, Marie-José Blouin, Elena Birman, et al.
Cancer Causes & Control : CCC|September 13, 2011
A prospective study of intakes of zinc and heme iron and colorectal cancer risk in men and womenXuehong Zhang, Edward L Giovannucci, Stephanie A Smith-Warner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2008
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisBora Gurel, Tsuyoshi Iwata, Cheryl M Koh, et al.
Cancer|April 22, 2011
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutationsLouise Bordeleau, Lorraine Lipscombe, Jan Lubinski, et al.
Oncogene|May 5, 2005
A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer modelNoreen Majeed, Marie-José Blouin, Paula J Kaplan-Lefko, et al.
Genes & Cancer|January 4, 2014
Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate CancerErin Muhlbradt, Jing Ma, Gianluca Severi, et al.
Pageof 24